Skip to main content
Clinical Trials/ACTRN12613001103752
ACTRN12613001103752
Completed
未知

Randomised controlled trial of tissue adhesive, absorbent dressings or external stabilisation devices versus standard care (bordered polyurethane) dressings to prevent central venous access device failure in hospital patients with central venous access devices: the CASCADE trial

Griffith University0 sites2,444 target enrollmentOctober 2, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Central venous access device failure prior to completion of therapy
Sponsor
Griffith University
Enrollment
2444
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 2, 2013
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Informed written consent
  • 2\. CVAD to be inserted for clinical care (includes peripherally inserted central catheters, percutaneous central catheters, tunnelled central catheters).

Exclusion Criteria

  • 1\. Current bloodstream infection
  • 2\. Non\-English speaking patients without interpreter
  • 3\. CVADS inserted through diseased, burned or scarred skin
  • 4\. Current skin tear/'paper' skin at high risk of tear
  • 5\. Known allergy to any study product
  • 6\. Extremely diaphoretic patients

Outcomes

Primary Outcomes

Not specified

Similar Trials